Study of GSK3359609 With Pembrolizumab and 5-fluorouracil (5-FU)-Platinum Chemotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
PHASE3
The purpose of this study is to evaluate if the addition of GSK3359609 to p...
Platform Study of Belantamab Mafodotin as Monotherapy and in Combination With Anti-cancer Treatments in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
PHASE1
B-cell maturation antigen (BCMA) is a target present on tumor cells in part...
Study of GSK3359609 and Pembrolizumab in Programmed Death Receptor 1-ligand 1 (PD-L1) Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
PHASE3
The purpose of study is to evaluate if the addition of GSK3359609 to pembro...